rs1554679825
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000507.4(FBP1):c.779delG(p.Gly260GlufsTer17) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000507.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- fructose-1,6-bisphosphatase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FBP1 | NM_000507.4 | c.779delG | p.Gly260GlufsTer17 | frameshift_variant | Exon 6 of 7 | ENST00000375326.9 | NP_000498.2 | |
| FBP1 | NM_001127628.2 | c.779delG | p.Gly260GlufsTer17 | frameshift_variant | Exon 7 of 8 | NP_001121100.1 | ||
| FBP1 | XM_006717005.5 | c.533delG | p.Gly178GlufsTer17 | frameshift_variant | Exon 6 of 7 | XP_006717068.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Fructose-biphosphatase deficiency Pathogenic:1
This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the FBP1 protein in which other variant(s) (p.Ser321Valfs*13) have been determined to be pathogenic (PMID: 28420223, 28776561). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 526506). This variant has not been reported in the literature in individuals affected with FBP1-related conditions. This sequence change creates a premature translational stop signal (p.Gly260Glufs*17) in the FBP1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 79 amino acid(s) of the FBP1 protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at